Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:1439-1445
Published online before print April 27, 2006, doi: 10.1161/01.RES.0000224120.52792.10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/11/1439    most recent
01.RES.0000224120.52792.10v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Y.
Right arrow Articles by Flavahan, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y.
Right arrow Articles by Flavahan, N. A.
Related Collections
Right arrow Other Vascular biology
Right arrowRelated Article
(Circulation Research. 2006;98:1439.)
© 2006 American Heart Association, Inc.


Integrative Physiology

Increased Expression of Cyclooxygenase-2 Mediates Enhanced Contraction to Endothelin ETA Receptor Stimulation in Endothelial Nitric Oxide Synthase Knockout Mice

Yingbi Zhou, Srabani Mitra*, Saradhadevi Varadharaj*, Narasimham Parinandi, Jay L. Zweier, Nicholas A. Flavahan

From the Davis Heart & Lung Research Institute, The Ohio State University, Columbus.

Correspondence to Yingbi Zhou, MD, PhD, Heart & Lung Research Institute, The Ohio State University, 473 W 12th Ave, Rm 545, Columbus, OH 43210. E-mail zhou-4{at}medctr.osu.edu

The aim of this study was to determine whether prolonged loss of NO activity, in endothelial NO synthase knockout (eNOS–/–) mice, influences endothelin (ET) ETA receptor-mediated smooth muscle contraction and, if so, to define the underlying mechanism(s). In isolated endothelium-denuded abdominal aortas, contractions to the selective ETA receptor agonist ET-1(1-31) were significantly increased in aortas from eNOS–/– compared with wild-type (WT) mice. In contrast, contractions to the {alpha}1-adrenergic agonist phenylephrine or the thromboxane (TX) A2 analog U-46619 were similar between eNOS–/– and WT mice. Immunofluorescent and Western blot analysis demonstrated that the aortic expression of ETA receptors was decreased in eNOS–/– compared with WT mice. Contractions evoked by ET-1(1-31), but not phenylephrine, were reduced by inhibition of cyclooxygenase-2 (COX-2) (indomethacin or celecoxib) or of TXA2/prostaglandin H2 receptors (SQ-29548). After COX inhibition, contractions to ET-1(1-31) were no longer increased and were actually decreased in eNOS–/– compared with WT aortas. Western blot analysis revealed that endothelium-denuded abdominal aortas express COX-2, but not COX-1, and that expression of COX-2 was significantly increased in eNOS–/– compared with WT mice. Contractions to the COX substrate arachidonic acid were also increased in eNOS–/– aortas. Furthermore, ET-1(1-31) but not phenylephrine stimulated production of the TXA2 metabolite TXB2, which was increased in eNOS–/– compared with WT aortas. Therefore, COX-2 plays a crucial and selective role in ETA-mediated smooth muscle contraction. Furthermore, COX-2 expression is increased in eNOS–/– mice, which overcomes a reduced expression of ETA receptors and enables a selective increase in contraction to ETA receptor stimulation.


Key Words: endothelin-1(1-31) • arachidonic acid • thromboxane A2 • prostaglandin H2


Related Article:

COX-2, Another Important Player in the Nitric Oxide–Endothelin Cross-Talk: Good News for COX-2 Inhibitors?
Ulrich Hink and Thomas Münzel
Circ. Res. 2006 98: 1344-1346. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Syeda, E. Tullis, A. S. Slutsky, and H. Zhang
Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2769 - H2774.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. R. Ansari, A. Nadeem, S. L. Tilley, and S. J. Mustafa
Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3448 - H3455.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Smani, A. Dominguez-Rodriguez, A. Hmadcha, E. Calderon-Sanchez, A. Horrillo-Ledesma, and A. Ordonez
Role of Ca2+-Independent Phospholipase A2 and Store-Operated Pathway in Urocortin-Induced Vasodilatation of Rat Coronary Artery
Circ. Res., November 26, 2007; 101(11): 1194 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. Hink and T. Munzel
COX-2, Another Important Player in the Nitric Oxide-Endothelin Cross-Talk: Good News for COX-2 Inhibitors?
Circ. Res., June 9, 2006; 98(11): 1344 - 1346.
[Full Text] [PDF]